Century Therapeutics (IPSC) Current Leases (2022 - 2025)
Historic Current Leases for Century Therapeutics (IPSC) over the last 4 years, with Q2 2025 value amounting to $4.9 million.
- Century Therapeutics' Current Leases rose 3360.63% to $4.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $4.9 million, marking a year-over-year increase of 3360.63%. This contributed to the annual value of $4.9 million for FY2024, which is 22187.71% up from last year.
- Latest data reveals that Century Therapeutics reported Current Leases of $4.9 million as of Q2 2025, which was up 3360.63% from $4.9 million recorded in Q1 2025.
- In the past 5 years, Century Therapeutics' Current Leases registered a high of $4.9 million during Q2 2025, and its lowest value of $475000.0 during Q4 2022.
- In the last 4 years, Century Therapeutics' Current Leases had a median value of $3.7 million in 2024 and averaged $3.1 million.
- Its Current Leases has fluctuated over the past 5 years, first surged by 22187.71% in 2024, then soared by 3360.63% in 2025.
- Over the past 4 years, Century Therapeutics' Current Leases (Quarter) stood at $475000.0 in 2022, then soared by 218.53% to $1.5 million in 2023, then soared by 221.88% to $4.9 million in 2024, then increased by 0.49% to $4.9 million in 2025.
- Its Current Leases was $4.9 million in Q2 2025, compared to $4.9 million in Q1 2025 and $4.9 million in Q4 2024.